New York, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today a new research program called MDA Kickstart for Ultra-Rare Neuromuscular Disease. The MDA ...
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the ...
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSXV: MSCL) (OTCQB: MSCLF), a publicly traded biotech company developing new small molecule therapeutic approaches to ...
UK researchers have identified the early stages of muscular dystrophy, which could aid in the early detection of the disease. The findings, which appear in the latest edition of the journal Disease ...
- Publication in Human Gene Therapy provides rationale for the use of microdystrophin expression levels as a surrogate endpoint reasonably likely to predict clinical benefit for AAV gene therapy ...
New model of muscular dystrophy provides insight into disease development Muscular dystrophy is a complicated set of genetic diseases in which genetic mutations affect the various proteins that ...
A 'conductor' has been discovered in the development of muscle tissue. The discovery could have an important impact on the treatment of muscular diseases such as myopathies and muscular dystrophies.
The contribution of selected physical development and muscular strength measures to general motor performance capacity was investigated in 55 seven to twelve year old boys. The physical development ...
Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback